Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ono Venture Investment Fund I, L.P. (OVI FI) is a corporate venture capital fund established in May 2020 in California, USA. It is managed by Ono Venture Investment, Inc. (OVI), the CVC arm of Ono Pharmaceutical Co., Ltd. The fund invests in early-stage biotech startups with innovative platforms in CNS, oncology, immunology, and related healthcare areas to access novel drug targets and technologies. Its investment pool was increased from US$100 million to US$200 million in December 2023 and has invested in 11 bio-ventures as of latest updates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ono Venture Investment Fund I, L.P..